STAGE IV UVEAL MELANOMA AJCC V7
Clinical trials for STAGE IV UVEAL MELANOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UVEAL MELANOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV UVEAL MELANOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare eye cancer: drug targets tumor growth
Disease control OngoingThis study tests a drug called vorinostat in 40 people with uveal melanoma that has spread to other parts of the body. Vorinostat works by blocking certain enzymes that cancer cells need to grow. The goal is to see if the drug can shrink or control the tumors, and to track how lo…
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New drug combo shows promise for rare eye cancer
Disease control OngoingThis study tests two treatments for uveal melanoma that has spread. One group gets trametinib alone, the other gets trametinib plus GSK2141795. The goal is to see which slows tumor growth better. About 42 adults with advanced disease are taking part.
Matched conditions: STAGE IV UVEAL MELANOMA AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:53 UTC